# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Sep 21, 2020

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2020-09-21
- Accepted by EDGAR: Sep 21, 2020, 16:14 ET
- Period: 2020-09-18
- Accession: 0000875320-20-000037
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000087532020000037/vrtx-20200918.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000087532020000037/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000087532020000037/vrtx-20200918.htm

Filed Sep 21, 2020.
Source: SEC EDGAR, the filing index for accession 0000875320-20-000037. Last ingested by Listed: Nov 6, 2026, 12:56 ET. No prices; not investment advice.